Benralizumab improves symptoms of patients with severe, eosinophilic asthma with a diagnosis of nasal polyposis - Archive ouverte HAL Access content directly
Journal Articles Allergy Year : 2022

Benralizumab improves symptoms of patients with severe, eosinophilic asthma with a diagnosis of nasal polyposis

Giorgio Walter Canonica
Tim Harrison
  • Function : Author
Pascal Chanez
  • Function : Author
Centre recherche en CardioVasculaire et Nutrition = Center for CardioVascular and Nutrition research
Francesco Menzella
Renaud Louis
  • Function : Author
Borja Cosio
Njira Lugogo
  • Function : Author
Arjun Mohan
  • Function : Author
Annie Burden
  • Function : Author
Esther Garcia Gil
  • Function : Author

Domains

Life Sciences [q-bio]

GUILLAUME RANCHON  : Connect in order to contact the contributor

https://hal-amu.archives-ouvertes.fr/hal-03800929

Submitted on : Thursday, October 6, 2022-4:35:14 PM

Last modification on : Friday, October 7, 2022-4:43:19 AM

Not file

Dates and versions

hal-03800929 , version 1 (06-10-2022)

Identifiers

Cite

Giorgio Walter Canonica, Tim Harrison, Pascal Chanez, Francesco Menzella, Renaud Louis, et al.. Benralizumab improves symptoms of patients with severe, eosinophilic asthma with a diagnosis of nasal polyposis. Allergy, 2022, 77 (1), pp.150-161. ⟨10.1111/all.14902⟩. ⟨hal-03800929⟩

Export

BibTeX TEI Dublin Core DC Terms EndNote Datacite

Collections

UNIV-AMU INRAE INCIAM
12 View
0 Download

Altmetric

Share

Gmail Facebook Twitter LinkedIn More